JPRN-UMIN000006332已完成未知
Phase II study of induction chemotherapy with gemcitabine and S-1 followed by chemoradiotherapy with S-1 in patients with locally advanced pancreatic cancer - Phase II study of induction chemotherapy with gemcitabine and S-1 followed by chemoradiotherapy with S-1 in patients with locally advanced pancreatic cancer
Chiba Cancer Center0 个研究点目标入组 30 人开始时间: 2011年9月12日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 80years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •(1)severe concurrent disease (2)interstitial pneumonia, severe pulmonary emphysema or active pnemonia (3)mental disorder (4)active concomitant malignancy (5)moderate or severe diarrhea, hemorrhagic colitis or peptic ulcer (6)severe drug hypersensitibity (7)pregnant or lactating females (8)regular use of phenytoin, warfarin or frucitocin (9)Under treatment with systemic steroid (10)fever of 38 degrees centigrade or higher, or infection requiring systemic treatment (11)inappropriate for entry onto the study, as diagnosed by primary physician
研究者
相似试验
招募中
不适用
A Phase I study of adjuvant chemotherapy with gemcitabine plus S-1 in patients with biliary tract cancer undergoing curative resection without major hepatectomyBiliary tract cancer undergoing curative resection without major hepatectomyJPRN-UMIN000007454Kansai Hepatobiliary Oncology Group (KHBO)24
已完成
不适用
A Phase I study of adjuvant chemotherapy with gemcitabine plus cisplatin in patients with biliary tract cancer undergoing curative resection without major hepatectomyBiliary tract cancer undergoing curative resection without major hepatectomyJPRN-UMIN000004622Kansai Hepatobiliary Oncology Group (KHBO)24
已完成
不适用
Phase II study of adjuvant chemotherapy with gemcitabine and regional arterial infusion of nafamostat mesilate for the patients with resectable pancreatic cancerJPRN-UMIN000006163Jikei University school of Medicine30
已完成
不适用
Phase II study of combination chemotherapy of gemcitabine, TS-1 and regional arterial infusion of nafamostat mesilate for advanced pancreatic cancer.nresectable advanced pancreatic cancerJPRN-UMIN000006161Jikei University school of Medicine30
已完成
不适用
Phase II study of combination chemotherapy of gemcitabine, TS-1 and regional arterial infusion of nafamostat mesilate for advanced pancreatic cancer.nresectable advanced pancreatic cancerJPRN-UMIN000008413Jikei University School of Medicine30